Acadia Healthcare Q3 2024 Earnings Report
Key Takeaways
Acadia Healthcare reported an 8.7% increase in revenue, totaling $815.6 million for Q3 2024. Net income attributable to Acadia was $68.1 million, or $0.74 per diluted share, while adjusted income was $84.1 million, or $0.91 per diluted share. The company is on track to expand its facilities and bed capacity.
Revenue totaled $815.6 million, an increase of 8.7% over the third quarter of 2023.
Same facility revenue increased 8.6% compared with the third quarter of 2023, including an increase in revenue per patient day of 3.6% and an increase in patient days of 4.7%.
Net income attributable to Acadia totaled $68.1 million, or $0.74 per diluted share.
Adjusted income attributable to Acadia totaled $84.1 million, or $0.91 per diluted share.
Acadia Healthcare
Acadia Healthcare
Forward Guidance
Acadia revised its financial guidance for 2024, anticipating revenue between $3.150 to $3.165 billion and adjusted earnings per diluted share between $3.35 and $3.45.
Positive Outlook
- Revenue between $3.150 to $3.165 billion.
- Adjusted EBITDA between $725 to $735 million.
- Adjusted earnings per diluted share between $3.35 to $3.45.
- Operating cash flows $525 to $550 million
- Total bed additions, excluding acquisitions approximately 1,200 beds
Challenges Ahead
- Interest expense $110 to $120 million
- Tax rate not specified
- Depreciation and amortization expense $145 to $155 million.
- Stock compensation expense $40 to $45 million.
- Expansion capital expenditures $550 to $595 million